EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Polymer-drug conjugates: revolutionizing nanotheranostic agents for diagnosis and therapy

Ashish Kumar Parashar, Gaurav Kant Saraogi, Pushpendra Kumar Jain, Balakdas Kurmi, Vivek Shrivastava, Vandana Arora

Discover Oncology · 11.11.2024 · 15 (1)

DOI: 10.1007/s12672-024-01509-9 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Discover Oncology, online erschienen am 11.11.2024. Verfasst von Ashish Kumar Parashar und 5 weiteren Autor:innen. Beteiligte Einrichtung: Lloyd Institute of Management and Technology, Plot No.-11, Knowledge Park-II, Greater Noida, Uttar Pradesh, India, 201306. ashish.parashar1@gmail.com. Die Arbeit wurde bisher 57-mal zitiert (Crossref) und nennt 119 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nanotheranostics, an amalgamation of therapeutic and diagnostic capabilities at the nanoscale, is revolutionizing personalized medicine. Polymer-drug conjugates (PDCs) stand at the forefront of this arena, offering a multifaceted approach to treat complex diseases such as cancer. This review explores the recent advancements in PDCs, highlighting their design principles, working mechanisms, and the therapeutic applications. We discuss the incorporation of imaging agents into PDCs that allow for real-time monitoring of drug delivery and treatment efficacy. With the aim of improving patient care, the review examines how PDCs enable targeted drug delivery, minimize side effects, and provide valuable diagnostic data, hence enhancing the precision of medical interventions. We also address the challenges facing the clinical translation of PDCs, such as scalability, regulatory hurdles, and cost-effectiveness, providing a comprehensive outlook on the future of nanotheranostics in patient management.

Schlagwörter

Stichwörter der Autor:innen

Imaging agentsNanomedicineNanotheranosticsPolymer-drug conjugatesPrecision medicineTargeted drug delivery

Autor:innen und Institutionen

  • Lloyd Institute of Management and Technology, Plot No.-11, Knowledge Park-II, Greater Noida, Uttar Pradesh, India, 201306. ashish.parashar1@gmail.com.
  • Sri Aurobindo Institute of Pharmacy, Indore, India.
  • IIMT College of Pharmacy, Greater Noida, India.
  • Department of Pharmaceutics, ISF College Pharmacy, GT Road, Moga, 142001, Punjab, India.
  • School of Pharmacy, Parul University, Vadodara, 391760, India.
  • Lloyd Institute of Management and Technology, Plot No.-11, Knowledge Park-II, Greater Noida, Uttar Pradesh, India, 201306.

Zitieren

APA

Parashar, A. K., Saraogi, G. K., Jain, P. K., Kurmi, B., Shrivastava, V., & Arora, V. (2024). Polymer-drug conjugates: revolutionizing nanotheranostic agents for diagnosis and therapy. Discover Oncology, 15(1). https://doi.org/10.1007/s12672-024-01509-9

Vancouver

Parashar AK, Saraogi GK, Jain PK, Kurmi B, Shrivastava V, Arora V. Polymer-drug conjugates: revolutionizing nanotheranostic agents for diagnosis and therapy. Discover Oncology. 2024;15(1). doi:10.1007/s12672-024-01509-9

BibTeX
@article{Parashar2024,
  author = {Parashar, Ashish Kumar and Saraogi, Gaurav Kant and Jain, Pushpendra Kumar and Kurmi, Balakdas and Shrivastava, Vivek and Arora, Vandana},
  title = {Polymer-drug conjugates: revolutionizing nanotheranostic agents for diagnosis and therapy},
  journal = {Discover Oncology},
  year = {2024},
  volume = {15},
  number = {1},
  doi = {10.1007/s12672-024-01509-9}
}
Kostenlos starten →